Nanotechnology in Drug Delivery: Achievements, Challenges, and Future Directions
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 30 August 2024 | Viewed by 112
Special Issue Editors
Interests: nanomaterials; bionanotechnology; nanotechnology in drug delivery; microfluidics; bioanalytical chemistry; liquid chromatography; mass spectrometry; niosomes formulation; extracellular vesicles
Interests: functionalized carbon nanoparticles; drug delivery; hydrogels; microfluidics; extracellular vesicles (EVs); drug controlled release; carbon nano-dots; fluorescence
Special Issue Information
Dear Colleagues,
The field of drug delivery for (bio)therapeutic agents has undergone a true conceptual revolution due to their merger with nanotechnology. The incorporation of nanomaterials into conventional drug delivery systems, serving as a functional agent for an improved targeted distribution, e.g., thermal or chemical-induced release, or as bioactive principles in their own right, represents just the tip of the iceberg in this vast scientific domain. Enhanced and innovative methods for distributing bioactive compounds or elements empower physicians to optimize drug dosages and, more importantly, target hard-to-reach tissues by opening new avenues for treatments. It is worth noting that some bioactive nanomaterials are devoid of undesirable consequences, such as antibiotic resistance, as seen in certain metal oxide nanoparticles.
Furthermore, nanotechnological approaches aimed at more efficient production strategies, particularly those based on micro/nanofluidics, have propelled innovative therapies with improved characteristics. Most importantly, these approaches often result in fewer, if any, secondary effects, thus enhancing the overall patient experience.
This Special Issue presents a technologically and conceptually comprehensive update on this highly impactful subject. This topic holds immense significance in a world where increased lifespan and evolving social behaviors necessitate efficient therapies for a broad spectrum of highly prevalent syndromes.
Dr. Pablo García-Manrique
Dr. Rosana Badía
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- (bio)nanotechnology
- drug delivery
- mimetic chemistry
- synthetic biology
- supra-molecular (bio)chemistry
- nanotherapeutic agents
- micro/nanofluidics
- bioactive materials
